Niren Thanky and Lynn LaPierre, consultants from Spencer Stuart, join Becker's Healthcare to discuss the biopharma and life sciences industry trends they are watching for in 2025. They delve into the impacts of AI, GLP-1 drugs, private equity investment, and more, exploring their implications for leadership and the broader industry.
This episode is sponsored by Spencer Stuart.
Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.
Becker's Websites
Virtual Learning
Conferences
Contact Us
Thank you so much for your interest in our content. Please register to access this complimentary archived content. By registering, you will receive our newsletter which can be opted out of at any time.
Already Registered? Click here to confirm.